Acquired in-process research and development is considered as:

Multiple Choice

• A definite-lived asset subject to amortization.
• A definite-lived asset subject to testing for impairment.
• An indefinite-lived asset subject to amortization.
• An indefinite-lived asset subject to testing for impairment.
• A research and development expense at the date of acquisition.